Research - Rare Renal

Rare Disease Group Trial Name Company Chief Investigator Study Sites Study details
Membranous Nephropathy Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy Novartis Dr Durga Kanigicherla Cardiff, Salford,Manchester, Leicester and Royal Free https://clinicaltrials.gov/ct2/show/NCT04154787

Details about research using RaDaR data are to be found under the 'Reports' section of specific Rare Disease Groups (RDGs)

Here is a summary of top level metadata on each cohort in RaDaR, numbers represent the number patients.

Details about what RaDaR data is available here

More details about how to use RaDaR data can be found by clicking here

Guidelines

NICE accredited clinical practice guidelines 

Available here

22nd Annual Report

Analyses about care provided to patients at UK renal centres.

Read the report

UKRR AKI Report

A report on the nationwide collection of AKI warning test scores. 

Read the report